B-TEK Science and Capabilities
The Emerging Threat Laboratory enables studies of high toxicity compounds.
B Division uses basic science and molecular tool development to understand host and pathogen interactions for detection and the discovery of novel therapeutics.
- Molecular tools for novel therapeutics discovery
- Novel in vitro methods to generate high-quality affinity reagents
Read more about recent work to generate antibodies that recognize SARS-CoV-2
Read more about using AI to develop vaccines and therapeutics
Scientists in Bioscience Division use novel techniques to study toxicology and health —as well as to develop countermeasures and therapeutics.
- Organ platforms for toxicological studies
- Advanced Tissue-engineered Human Ectypal Network Analyzer (ATHENA)
- Award-winning lung model: PuLMo
- Skin models
- Neuromuscular junctions
- Microfluidics and gel microdroplet technology that enable high-throughput interrogation of cell-to-cell interactions (HiSCI)
- Therapies for enteric pathogens
- Radioimmunotherapies for countering antimicrobial resistance
Read more about recent MPS work:
Identifying biomarkers of radiation exposure
The laboratories in B-TEK are equipped with several NMR spectrometers, ranging from 300-700 MHz. In addition, our scientists have developed unique, portable, ultra-low magnetic field platforms for chemical threat detection and characterization.
Recent innovations using low-field NMR have been recipients of R&D 100 awards. Learn more about SEDONA and ERDE.
B-TEK scientists use classical biochemistry methods combined with NMR and Mass Spectrometry-based approaches to study enzymes, regulation, as well as the discovery of novel enzyme effectors and therapeutic molecules.
- LANL has hosted a stable isotope capability since 1974
- Synthesis of all classes of chemical compounds
- Stable isotope labels for tracing, detection, attribution, and mechanistic studies
- In-cell biosensor development
- Chemical catalysis and conversion for drop-in fuels and commodity chemicals
- Enzyme function discovery and detection
- Peptoid foldamer development
- Small molecule synthesis
Recognized as a leader in genomic sequencing and analysis for decades, the Los Alamos capability now spans all ‘omics research to study proteins, metabolites, and lipids. By combining techniques in genomics and mass spectrometry, B-Division is working towards a true systems-level characterization of biological organisms.
The collection of equipment available at Los Alamos combined with our experience and expertise using mass spectrometry enables a wide range of research endeavors.
- Targeted and untargeted metabolomics
- Targeted and shotgun proteomics
- Lipidomics
State-of-the-art mass spectrometers available:
- Thermo Fisher Orbitrap Eclipse
- Thermo Fisher Exploris 480
- Thermo Fisher Altis QQQ
- Thermo Fisher QE
- Additional instrumentation available
For more information email BTEKOmics@lanl.gov
